References 1 Molecular MedicineARA 290, a peptide derived from the helix-B of erythropoietin, that selectively activates the innate repair receptor
First IND application February 2024 (Korea)
The glucagon receptor component may contribute to sustained appetite suppression through metabolic mechanisms that are less susceptible to tolerance
Diabetes Care 33(2):428433 Eguchi Y, Kitajima Y, Hyogo H, Takahashi H, Kojima M, Ono M et al (2015) Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J)
What are the possible drawbacks of taking GLP-1 or dual GLP-1/GIP agonists for 10 to 20 years
Unlike many weight loss approaches that fight your biology, GLP-1 therapy works with your body's natural systems